<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00755586</url>
  </required_header>
  <id_info>
    <org_study_id>40-41200-98-040</org_study_id>
    <nct_id>NCT00755586</nct_id>
  </id_info>
  <brief_title>Stem Cell Therapy to Improve the Muscle Function of Patients With Partly Denervated Muscles of the Arm</brief_title>
  <official_title>Autologous Bone Marrow Transplantation for Muscle Improvement in Traumatic Brachial Plexus Injuries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess muscle improvement after stem cell injection in the
      biceps muscle of patients with a brachial plexus injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Brachial plexus injuries can cause severe disabilities and often affect young adults and
      newborn children. When initial conservative treatment or nerve surgery fails, muscle/tendon
      transfers are the only current treatment options available to regain a functional arm. During
      this extensive surgery a healthy donor muscle is transposed to exert a different function.
      After long-term denervation the muscle is irreversibly changed. Muscle atrophy, fattening,
      fibrosis, decrease in capillary to muscle fiber ratio and decline in the number of satellite
      cells, which are responsible for post-natal muscle repair, is seen. For neuromuscular
      diseases, cell therapy aiming at rescuing muscle damage by delivery of cells that can
      differentiate into skeletal muscle, might be a promising approach. Safety questions remain
      whether stem cell injection results in non-muscle tissue formation like inflammatory cells or
      connective tissue formation in the transplanted muscles. Furthermore, it remains to be
      determined whether these stem cells undergo functional integration and enhance muscle
      function. The objective of this pilot study is to assess functional and morphological
      improvement of the m. biceps brachii after autologous bone marrow-derived mononuclear cell
      injection.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">January 2011</completion_date>
  <primary_completion_date type="Anticipated">January 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess muscle improvement, muscle biopsies, quantitative needle EMGs, muscle density analysis, force measurement, range of motion of the elbow joint and quality of life questionnaires will be performed.</measure>
    <time_frame>Two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary research aim of this study is to assess vital signs and to detect signs of hematoma and/or injection at the bone marrow aspiration site, injection site and/or surgical wound.</measure>
    <time_frame>Two years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Brachial Plexus Injury</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mononuclear cell injection: 4 * 10e8 cells</intervention_name>
    <description>350 ml bone marrow will be aspirated from the posterior iliac crest under general anesthesia in combination with a muscle tendon transposition surgery. Next, the patients will receive a bone marrow derived mononuclear cell injection of 4 * 10e8 cells in the m. biceps brachii.</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mononuclear cell injection: 8 * 10e8 cells</intervention_name>
    <description>650 ml bone marrow will be aspirated from the posterior iliac crest under general anesthesia in combination with a muscle tendon transposition surgery. Next, the patients will receive a bone marrow derived mononuclear cell injection of 8 * 10e8 cells in the m. biceps brachii.</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No mononuclear cell injection</intervention_name>
    <description>Patients will receive a muscle tendon transposition surgery without bone marrow aspiration or mononuclear cell injection.</description>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BP patients with paresis of m. biceps brachii (MRC 1,2,3), either after conservative
             treatment or at least two years after nerve surgery with partial recovery of the elbow
             flexor

          -  Patients capable and willing to give informed consent

        Exclusion Criteria:

          -  Function recovery of the elbow flexor (m. biceps brachii) to a MRC motor scale of 0

          -  EMG activity: no motor unit potentials

          -  Medical history of other central of peripheral neurological disorders

          -  Inability to undergo BM harvesting

          -  Bleeding diathesis, INR &gt; 2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rob GHH Nelissen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Leiden University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rob GHH Nelissen, MD, PhD</last_name>
    <phone>0031715263606</phone>
    <email>r.g.h.h.nelissen@lumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <zip>2300RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bouke J Duijnisveld, MD, MSc</last_name>
      <phone>0031715263606</phone>
      <email>b.j.duijnisveld@lumc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Rob GHH Nelissen, MD, PhD</last_name>
      <phone>0031715263606</phone>
      <email>r.g.h.h.nelissen@lumc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Rob GHH Nelissen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bouke J Duijnisveld, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2008</study_first_submitted>
  <study_first_submitted_qc>September 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2008</study_first_posted>
  <last_update_submitted>August 17, 2009</last_update_submitted>
  <last_update_submitted_qc>August 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof.dr. R.G.H.H. Nelissen</name_title>
    <organization>Leiden University Medical Center, department of orthopaedics</organization>
  </responsible_party>
  <keyword>Brachial plexus</keyword>
  <keyword>Muscle denervation</keyword>
  <keyword>Stem cell transplantation</keyword>
  <keyword>Bone marrow cells</keyword>
  <keyword>Satellite cells</keyword>
  <keyword>Fibrosis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

